Staphylococcus aureus Panton-Valentine Leukocidin worsens acute implant-associated osteomyelitis in humanized BRGSF mice

Marloes I. Hofstee
AO Research Institute Davos
January 4, 2024
JBMRplus
https://pubmed.ncbi.nlm.nih.gov/38505530/

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/38505530/

Research summary

This study investigates the role of Panton-Valentine leukocidin (PVL), a toxin produced by Staphylococcus aureus, in the severity of implant-associated osteomyelitis. Using humanized BRGSF mice, the research examines how PVL influences infection outcomes, immune cell dynamics, and bacterial dissemination.

Key outcome of the study

Mice infected with PVL-producing S aureus strains exhibited more severe clinical outcomes, including higher bacterial loads in bone and soft tissues, formation of staphylococcal abscess communities in bone marrow, and increased dissemination to internal organs. These findings highlight the pivotal role of PVL in exacerbating implant-associated osteomyelitis.

Mouse model

The study utilized humanized BRGSF mice, which are immunodeficient mice engrafted with human hematopoietic stem cells, leading to the development of a human-like immune system. This model allows for the assessment of human-specific immune responses to S. aureus infection.

TARGET:

Keywords

Osteomyelitis, Staphylococcus aureus, Panton-Valentine leukocidin, Humanized mouse model, Implant-associated infections

Technical specifications

Humanized BRGSF mice, Hematopoietic stem cell engraftment, Immune response assessment, Bacterial pathogenesis, Infection modeling

Related products

Catalogue product

genO‑BRGSF‑HIS

genO‑BRGSF‑HIS mice possess the most functional reconstituted human immune system currently on the market and are highly relevant for translational research.

Customized product

No items found.